
Sigilon Therapeutics SGTX
Quarterly report 2023-Q2
added 05-23-2026
Sigilon Therapeutics ROA Ratio 2011-2026 | SGTX
Annual ROA Ratio Sigilon Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -49.91 | -53.55 | -24.26 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -24.26 | -53.55 | -42.58 |
Quarterly ROA Ratio Sigilon Therapeutics
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -45.66 | -43.14 | -33.5 | -45.81 | -47.63 | -43.6 | -32.61 | -56.88 | -68.83 | -82.11 | -72.78 | -24.26 | -24.26 | -24.26 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -24.26 | -82.11 | -46.1 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-241.53 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-22.19 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
-275.96 | - | -10.17 % | $ 12.2 K | ||
|
Coherus BioSciences
CHRS
|
65.04 | $ 1.73 | 5.18 % | $ 203 M | ||
|
I-Mab
IMAB
|
7.43 | - | - | $ 866 M | ||
|
Celldex Therapeutics
CLDX
|
-44.38 | $ 31.65 | 2.59 % | $ 2.1 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
23.87 | - | 2.54 % | $ 160 B | ||
|
BioNTech SE
BNTX
|
-5.17 | $ 94.81 | 2.78 % | $ 22.9 B | ||
|
AstraZeneca PLC
AZN
|
8.97 | - | - | $ 96.9 B | ||
|
CRISPR Therapeutics AG
CRSP
|
-25.67 | $ 53.52 | 3.74 % | $ 4.81 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-114.6 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
-40.14 | - | 0.74 % | $ 768 M | ||
|
Compugen Ltd.
CGEN
|
22.57 | $ 2.68 | 1.13 % | $ 250 M | ||
|
Abcam plc
ABCM
|
-0.8 | - | - | $ 4.9 B | ||
|
Galera Therapeutics
GRTX
|
2071.28 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-35.12 | - | -18.52 % | $ 27.3 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
53.1 | $ 0.78 | 14.04 % | $ 35.6 M | ||
|
Esperion Therapeutics
ESPR
|
-4.87 | $ 3.13 | 0.32 % | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
-4.99 | $ 31.66 | 1.18 % | $ 852 M | ||
|
Affimed N.V.
AFMD
|
-109.04 | - | -34.95 % | $ 21.5 M | ||
|
Forte Biosciences
FBRX
|
-83.81 | $ 22.13 | 0.87 % | $ 287 M | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-77.89 | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
-207.62 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
-43.36 | - | -7.31 % | $ 87 M | ||
|
Galectin Therapeutics
GALT
|
-157.87 | $ 2.72 | -2.69 % | $ 174 M | ||
|
Generation Bio Co.
GBIO
|
-56.95 | - | - | $ 344 M | ||
|
IMV
IMV
|
-121.19 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M | ||
|
Grifols, S.A.
GRFS
|
0.99 | $ 8.08 | 0.9 % | $ 5.49 B | ||
|
Hutchison China MediTech Limited
HCM
|
26.06 | $ 11.72 | -0.26 % | $ 10.1 B | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
36.63 | - | -4.36 % | $ 27 M | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-102.69 | - | - | $ 384 M | ||
|
Heron Therapeutics
HRTX
|
-7.82 | $ 0.9 | 2.13 % | $ 150 M | ||
|
Gracell Biotechnologies
GRCL
|
-36.68 | - | - | $ 3.37 B | ||
|
Anika Therapeutics
ANIK
|
-5.72 | $ 14.76 | -0.87 % | $ 212 M | ||
|
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-48.33 | - | 5.93 % | $ 314 M | ||
|
InflaRx N.V.
IFRX
|
-82.65 | $ 2.6 | -5.11 % | $ 175 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-19.87 | - | 1.93 % | $ 17.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-103.3 | $ 3.35 | -4.83 % | $ 5.51 M |